Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048633
Status:
COMPLETED
Last Update Posted:
2012-05-23
First Post:
2002-11-04
Brief Title:
Phase II Study to Evaluate Tariquidar XR9576 a Selective MDR-1 Inhibitor in Chemotherapy Resistant Advanced Breast Cancer
Sponsor:
QLT Inc
Organization:
QLT Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Neoplasms |
Keywords:
| Name | View |
|---|---|
| Chemotherapy resistance advanced breast cancer | View |